M&G PLC decreased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 60.9% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 15,358 shares of the biotechnology company's stock after selling 23,957 shares during the period. M&G PLC's holdings in Axon Enterprise were worth $6,143,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of AXON. Motley Fool Asset Management LLC increased its position in Axon Enterprise by 238.7% during the 1st quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company's stock worth $153,981,000 after purchasing an additional 346,838 shares in the last quarter. 1832 Asset Management L.P. purchased a new position in shares of Axon Enterprise in the 1st quarter valued at $81,630,000. International Assets Investment Management LLC purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at $871,860,000. Vanguard Group Inc. lifted its holdings in shares of Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company's stock valued at $2,547,878,000 after acquiring an additional 212,401 shares in the last quarter. Finally, Swedbank AB purchased a new stake in Axon Enterprise during the 1st quarter worth $39,923,000. Hedge funds and other institutional investors own 79.08% of the company's stock.
Insiders Place Their Bets
In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total value of $167,863.50. Following the completion of the transaction, the director now directly owns 7,379 shares in the company, valued at $2,752,588.37. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $373.03, for a total value of $167,863.50. Following the sale, the director now directly owns 7,379 shares of the company's stock, valued at $2,752,588.37. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick W. Smith sold 80,300 shares of the business's stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares of the company's stock, valued at approximately $1,121,052,771.48. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 369,172 shares of company stock valued at $136,270,842. Company insiders own 6.10% of the company's stock.
Analyst Ratings Changes
A number of brokerages have commented on AXON. Barclays boosted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 7th. Robert W. Baird upped their price target on Axon Enterprise from $440.00 to $460.00 and gave the stock an "outperform" rating in a report on Monday, November 4th. Craig Hallum lifted their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a "buy" rating in a research note on Wednesday, August 7th. JMP Securities upped their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a research note on Thursday, October 31st. Finally, Northland Securities lifted their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an "outperform" rating in a research note on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, Axon Enterprise currently has a consensus rating of "Moderate Buy" and an average price target of $412.42.
Check Out Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Stock Up 28.7 %
NASDAQ:AXON traded up $134.43 during mid-day trading on Friday, reaching $603.18. The stock had a trading volume of 3,966,980 shares, compared to its average volume of 538,452. The stock's 50 day simple moving average is $414.16 and its two-hundred day simple moving average is $346.96. Axon Enterprise, Inc. has a 1-year low of $212.88 and a 1-year high of $611.88. The company has a market capitalization of $45.58 billion, a price-to-earnings ratio of 155.86, a price-to-earnings-growth ratio of 11.70 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating analysts' consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business had revenue of $504.00 million during the quarter, compared to the consensus estimate of $478.35 million. During the same period in the previous year, the business earned $0.80 EPS. The business's quarterly revenue was up 34.5% on a year-over-year basis. Equities analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current year.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for November 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.